291 related articles for article (PubMed ID: 12171541)
1. Chemotherapeutic potential of curcumin for colorectal cancer.
Chauhan DP
Curr Pharm Des; 2002; 8(19):1695-706. PubMed ID: 12171541
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells.
Goel A; Boland CR; Chauhan DP
Cancer Lett; 2001 Oct; 172(2):111-8. PubMed ID: 11566484
[TBL] [Abstract][Full Text] [Related]
3. Implications of low COX-2 expression in colorectal neoplasms with defective DNA mismatch repair.
Karnes WE
J Cell Biochem Suppl; 2000; 34():23-7. PubMed ID: 10762011
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
Plummer SM; Holloway KA; Manson MM; Munks RJ; Kaptein A; Farrow S; Howells L
Oncogene; 1999 Oct; 18(44):6013-20. PubMed ID: 10557090
[TBL] [Abstract][Full Text] [Related]
5. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
7. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
8. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
Sanborn R; Blanke CD
Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
[TBL] [Abstract][Full Text] [Related]
10. COX-2 in large bowel cancer: a one-sided story.
DuBOIS RN
Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
[No Abstract] [Full Text] [Related]
11. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.
Howe LR; Dannenberg AJ
Semin Oncol; 2002 Jun; 29(3 Suppl 11):111-9. PubMed ID: 12138405
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
13. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
Rao M; Yang W; Seifalian AM; Winslet MC
Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
[TBL] [Abstract][Full Text] [Related]
14. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib with chemotherapy in colorectal cancer.
Blanke CD
Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
[TBL] [Abstract][Full Text] [Related]
16. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
[TBL] [Abstract][Full Text] [Related]
17. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
Garcea G; Berry DP; Jones DJ; Singh R; Dennison AR; Farmer PB; Sharma RA; Steward WP; Gescher AJ
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):120-5. PubMed ID: 15668484
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents.
Plummer SM; Hill KA; Festing MF; Steward WP; Gescher AJ; Sharma RA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1295-9. PubMed ID: 11751448
[TBL] [Abstract][Full Text] [Related]
19. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.
Davies NM; Wallace JL
Drugs Aging; 1996 Dec; 9(6):406-17. PubMed ID: 8972241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
